Menu
Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 2
Review
Profile of brentuximab vedotin and its potential in the treatment of relapsed or refractory Hodgkin lymphoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 10,913 | Dovepress* | 10,913+ | 2,517 | 13,430 | |
| Totals | 10,913 | 2,517 | 13,430 | ||
|
*Since 21 May 2012 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 2 | 2 |
View citations on Google Scholar